[HTML][HTML] Molecular classifications in gastric cancer: A call for interdisciplinary collaboration

C Díaz del Arco, MJ Fernández Aceñero… - International Journal of …, 2024 - mdpi.com
Gastric cancer (GC) is a heterogeneous disease, often diagnosed at advanced stages, with
a 5-year survival rate of approximately 20%. Despite notable technological advancements in …

[HTML][HTML] Phenotyping Tumor Heterogeneity through Proteogenomics: Study Models and Challenges

D Piana, F Iavarone, E De Paolis, G Daniele… - International Journal of …, 2024 - mdpi.com
Tumor heterogeneity refers to the diversity observed among tumor cells: both between
different tumors (inter-tumor heterogeneity) and within a single tumor (intra-tumor …

Integrating single‐cell transcriptomics and machine learning to predict breast cancer prognosis: A study based on natural killer cell‐related genes

J Mao, L Liu, Q Shen, M Cen - Journal of Cellular and …, 2024 - Wiley Online Library
Breast cancer (BC) is the most commonly diagnosed cancer in women globally. Natural
killer (NK) cells play a vital role in tumour immunosurveillance. This study aimed to establish …

[HTML][HTML] Global research trends and prospects related to tumor microenvironment within Triple Negative Breast Cancer: a bibliometric analysis

P Li, J Li, X Tong, Z Xiao, W Diao, C Zhong… - Frontiers in …, 2023 - frontiersin.org
Background and aims The tumor microenvironment (TME) has pivotal parts within multiple
tumor models of onset/progression, such as triple-negative breast cancer (TNBC). This …

The shared role of neutrophils in ankylosing spondylitis and ulcerative colitis

T Chen, W Tan, X Zhan, C Zhou, J Zhu, S Wu, B Qin… - Genes & …, 2024 - nature.com
This study aimed to analyze single-cell sequencing data to investigate immune cell
interactions in ankylosing spondylitis (AS) and ulcerative colitis (UC). Vertebral bone marrow …

[HTML][HTML] Natural Killer T Cell Diversity and Immunotherapy

EI Tognarelli, C Gutiérrez-Vera, PA Palacios… - Cancers, 2023 - mdpi.com
Simple Summary Cell-based oncotherapies are gaining considerable terrain in the last
years thanks to the development of safe and promising treatments against cancer. A better …